Measure cognitive decline in Parkinsons
- Trial ID
- NCT04997642
- Official Title
- Parkinson's Disease and Movement Disorders Clinical Database
- Goal
- Measure cognitive decline in Parkinsons
- Status
- RECRUITING
- Sponsor
- University of Pennsylvania
- Study Type
- OBSERVATIONAL
- Enrollment
- 250 participants
- Conditions
- Parkinson Disease, Parkinson Disease Dementia, Lewy Body Parkinson Disease, Lewy Body Dementia With Behavioral Disturbance
- Interventions
- neuropsychiatric and cognitive testing questionnaires
Plain-Language Summary
The goal is to build a clinical database to better understand how thinking, memory and neuropsychiatric symptoms change over time in Parkinson's and related Lewy body disorders, so researchers can spot patterns and design better care and trials. Participants complete standardized cognitive tests and neuropsychiatric questionnaires about mood, behavior and daily thinking during routine visits, and those data are collected and tracked over time; this is observational, not a treatment trial. The database plans to enroll about 250 people. Adults 18 and older with a Parkinson's diagnosis who have mild cognitive impairment or dementia and who can complete the assessments are eligible, with no age or disease severity limits beyond the ability to participate.
Locations
- University of Pennsylvania, Philadelphia, Pennsylvania, United States
Frequently Asked Questions
- What is this trial testing?
- This trial is studying neuropsychiatric and cognitive testing questionnaires. The goal is to build a clinical database to better understand how thinking, memory and neuropsychiatric symptoms change over time in Parkinson's and related Lewy body disorders, so researchers can spot patterns and design better care and trials. Participants complete standardized cognitive tests and neuropsychiatric questionnaires about mood, behavior and daily thinking during routine visits, and those data are collected and tracked over time; this is observational, not a treatment trial. The database plans to enroll about 250 people. Adults 18 and older with a Parkinson's diagnosis who have mild cognitive impairment or dementia and who can complete the assessments are eligible, with no age or disease severity limits beyond the ability to participate.
- Who can participate?
- Participants must be at least 18 Years.
- Where is this trial located?
- This trial is recruiting at 1 location.
- Does it cost anything to join?
- No. There is no cost to participate. Study-related care and treatment are provided at no charge.
- How long does the trial last?
- This trial is estimated to last approximately 10 years.